Phase 2 trial begins testing benfotiamine (vitamin B1) in Alzheimer's
Louis shares news of an 18-month Phase 2 trial at Rutgers testing benfotiamine, a fat-soluble thiamine form, to improve cognition in Alzheimer's.
2 posts
Louis shares news of an 18-month Phase 2 trial at Rutgers testing benfotiamine, a fat-soluble thiamine form, to improve cognition in Alzheimer's.
Louis notes high-dose vitamin B1 may slow Alzheimer's and a large trial is testing benfotiamine, a fat-soluble B1, which may reach the brain better. Evidence is not yet in.